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Abstract 
Daniel M. Gatti : Genome-level analysis of genetic regulation of liver gene 
expression networks 
(Under the direction of Ivan Rusyn, M.D., Ph.D.) 
 
The liver is the primary site for metabolism of nutrients, drugs and chemical agents. While 
metabolic pathways are complex and tightly regulated, genetic variation among 
individuals, reflected in variation in gene expression levels, introduces complexity into 
research on liver disease. This study aimed to dissect genetic networks that control liver 
gene expression by combining large-scale quantitative mRNA expression analysis with 
genetic mapping in a reference population of BXD recombinant inbred mouse strains for 
which extensive SNP, haplotype and phenotypic data is publicly available.  We profiled 
gene expression in livers of naive mice of both sexes from C57BL/6J, DBA/2J, B6D2F1, 
and 37 BXD strains using Agilent oligonucleotide microarrays. This data was used to map 
quantitative trait loci (QTLs) responsible for variation in expression of about 19,000 
transcripts.  We identified polymorphic cis- and trans-acting loci, including several loci 
that control expression of large numbers of genes in liver. 
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CHAPTER 1 
 
Literature Review 
  
 With the recent sequencing of entire mammalian genomes1,2, the possibility exists 
that the genetic basis of liver injury can be unraveled.   Several high density genotyping 
projects are underway to sequence panels of inbred strains at densities of ~150,000 and 
~8.3 loci3,4, providing an unprecedented density of genomic information.  This detailed 
sequence data can be combined with high throughput gene expression microarrays to 
examine the effect of genetics on constitutive levels of gene expression5-7.  The 
combination of such high dimension data sets can offer insight into complex mechanisms 
of liver disease and toxicity8. 
 Liver injury is the primary reason that prospective drugs are pulled from clinical 
testing and such idiosyncratic liver responses account for up to 50% of liver failure cases9.  
While the drug in testing may behave as designed in most of the population, some 
proportion experiences serious and unpredicted toxicity.  This toxicity is typically not 
observed in animal models and has a low incidence in the general population10.   These 
properties make idiosyncratic liver injury extremely difficult to predict.  Further, if such 
reactions occur when patients are intentionally exposed to drugs, it is possible that 
environmental xenobiotics can have the same effects.  While most of the population does 
not experience an adverse response to common environmental exposures, a small 
percentage may experience an idiosyncratic response.  An increased understanding of 
 the mechanisms of toxicity in the liver will allow us to better predict and prevent such 
incidents. 
 All human populations are exposed to environmental toxins and toxicants.  
However, the response to such exposures is not uniform.  While the majority of the 
population may experience exposure and suffer no measurable injury, a minority may 
experience severe toxicity.  The reasons for such differential responses are many.  
Exposure dose and duration, lifestyle and nutritional choices, genetic differences and 
other variables can all affect the response.  In this study, the focus is specifically on the 
genetic differences that influence the differential response to toxic insult. 
 In order to study these genetic differences, mouse models are used.  Mice have 
been used in the study of many chemicals including 1,1,2-trichloroethylene11, cadmium12 
and 1,3-butadiene13.   Mice are preferable to simpler organisms because they are easy to 
house and feed, breed well and are mammalian systems with more similarity to humans 
than fish or insects.  They are also preferable to in vitro systems because cells in culture 
may or may not respond identically to cells in the body.  Further, in vivo systems retain 
the complex signaling interactions between disparate cell types within and between 
organs14,15.  
 In order to study the effect of genetic background on gene expression, mice with a 
controlled genotype are used.  Inbred strains are homozygous at all genomic loci and 
whose individuals have identical genotypes. These strains are developed through 
extended sibling mating for over 20 generations.  This process leads to increased 
homozygosity over at least 99% of the genome.  The use of inbred strains in genetics is 
well established and some strains have been bred and used in laboratory experiments for 
almost 100 years16.   The decreased genetic diversity within a single inbred strain leads 
to greatly reduced phenotypic variance, reducing the number of mice needed to detect 
statistically significant phenotypic differences.  The stable genotype is also invaluable for 
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 reproducing phenoptypic measurements in different laboratories.  Environmental factors 
can be varied in a controlled manner without additional genotypic variation17.   It is 
important to note that while the phenotypic variation within an inbred strain is reduced, 
the phenotypic variation among a panel of inbred strains can remain vast18.  
 The progeny of inbred mice can be bred in such a way that the genomes are 
permuted in a controlled manner.  Such recombinant inbred (RI) mice are inbred mice 
whose progenitors are themselves inbred mice.   These mice are produced by mating two 
inbred parents (i.e. C57BL/6J & DBA/2J) to produce an F1 generation.   The F1 litter is 
sibling mated to produce an F2 generation.  Each F2 generation is then sibling mated for 
over 20 generations to produce a unique RI line.  The naming of these lines uses an ‘X’ 
between a letter from each of the two progenitor strains.  For example, the C57BL/6J and 
DBA/2J derived RI line is called ‘BXD.’  The advantage of using RI strains is that they 
provide a known ancestry and a controlled mixing of genotypes while retaining the 
homozygosity and reduced intrastrain phenotypic variance of inbreds. 
  Quantitative Trait Locus (QTL) mapping has been used to associate a specific 
genotype with the variation in a single measured phenotype like high density 
lipoproteins19 and ethanol tolerance20.   At each locus in a segregating population, a 
model is fit which estimates the likelihood that this locus explains the variation in 
phenotype versus the likelihood that there is no genotypic effect on the phenotype.  
Interval mapping21 is a variation on QTL mapping which uses maximum likelihood 
estimation.  At each marker, the likelihood that the marker is associated with the 
phenotype over the likelihood that the marker is associated with no genotype is 
calculated.  This is the Likelihood Ratio Statistic (LRS).   Between markers, the exact 
genotype is unknown.  Because of this missing data, the expectation maximization 
algorithm is used to estimate the genotype based on recombination frequencies.  The 
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 result is a QTL plot of the entire genome with LRS scores indicating the strength of 
association between the phenotype and each genomic location. 
While QTL mapping was initially used with a single phenotype, the arrival of 
microarray technology allows for the measurement of thousands of phenotypes 
simultaneously.  Beginning with a study in yeast22, QTL mapping has been done with 
gene expression as the phenotype.  In such a study, the genomic loci responsible for 
variation in gene expression can be used to infer regulatory control.  While such a study 
is not conclusive, it can be used to narrow the potential regulatory candidates, generate 
hypotheses for further testing and construct regulatory networks in silico. 
 This approach has been applied in the mouse liver5,brain6 and hematopoetic stem 
cells7.  The liver study5 used an F2 population derived from C57BL/6J and DBA/2J to 
study the relationship of liver gene expression to fat pad mass.  The others 6,7 looked at 
constitutive gene expression in a panel of BXD RI mice to infer the regulation of basal 
gene expression.  These studies were significant in increasing our understanding gene 
regulatory networks including the existence of master regulator loci, clusters of co-
regulated genes and the association of gene expression with previously measured 
behavioral traits. 
 Missing from the current literature is a study of constitutive gene expression in the 
mouse liver using a panel of RI strains.  Such a study would lay a foundation of basic 
research for liver toxicologists and provide a resource which can be used to associate 
genes expression with phenotype measurements.  It could be used to find clusters of co-
regulated genes that may not have been otherwise associated in previous work and to 
build regulatory networks for genes relevant to xenobiotic metabolism.  Lastly, such a 
data set could be used for intelligent strain selection when a knockout model is otherwise 
unavailable. 
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CHAPTER 2 
Introduction 
 
 The maturation of gene expression technology has opened the door to the 
exploration of the genetics of gene expression 5,6,22.  Microarrays allow for the concurrent 
measurement of thousands of transcripts with the resultant genomic data being 
increasingly used to improve biological interpretation of data from mechanistic research.  
Phenotypic anchoring of observed phenotypes to gene expression changes has proven 
useful in uncovering the molecular mechanisms that lead to liver injury 23,24.  Such 
experiments connect the variation in transcript expression to phenotypes.  However, they 
do not lead to detailed gene expression networks where the expression of one gene is 
found control the expression of another.  
Recombinant Inbred (RI) mice are created by crossing two parental strains 
followed by sib-mating for over 20 generations 25.  Strains created this way have the 
advantage of being homozygous at almost every location along the genome.  As such, 
each representative of an RI line will have limited phenotypic variation within that line, but 
the variation between lines is usually vast. RI panels are widely used to determine 
genotype-phenotype associations using QTL mapping techniques 21. The relationships 
between phenotypes and genotypes are calculated using a likelihood ratio statistic (LRS), 
which is a measure of the probability that a given genetic marker explains the variation in 
the phenotype.  When mRNA levels are used as the phenotype, regions of the genome 
with a high LRS are likely to contain genes that control the expression of the gene 
 transcript being profiled; this process is referred to as expression Quantitative Trait Loci 
(eQTL) mapping 5,26.   
The BXD panel of RI strains was created from the C57BL/6J and DBA/2J parental 
strains 27,28. These two parental inbred strains are known to exhibit widely different 
phenotypes in response to a number of exposures. Thus, BXD mice have been a useful 
tool for elucidation of the genetic control of certain diseases. For example, the BXD lines 
have been used to study alcohol preference and tolerance 29, alcohol metabolism 30, 
responsiveness to aromatic hydrocarbons 31, N,N-diethylnitrosamine induced 
hepatocarcinogenesis 32 and diabetes and atherosclerosis 33,34.  Recently, BXD mice 
were used for eQTL studies that elucidated the genetics of gene expression in the brain 6 
and hematopoietic stem cells 7.   
The genetic basis and networks that control gene expression in the liver are not 
well delineated and improving our understanding of these pathways and controlling loci 
will advance knowledge of physiological and pathophysiological changes in this organ. 
Here, eQTL mapping was applied to data from genome-wide microarray profiling of liver 
gene expression in the naïve state of the parental C57BL/6J and DBA/2J strains, the F1 
cross and 37 BXD strains. Using this approach, potential key regulators of gene 
expression in the liver were identified. The comparison of the liver and brain 
transcriptome maps demonstrated tissue-specific differences in regulation of gene 
expression.  Finally, we demonstrate how the data collected in this study may be used to 
infer genotype-phenotype correlations, generate testable hypothesis, and identify strains 
that may differ in responsiveness to xenobiotics based on the genetically-determined 
differences in expression of the key genes.   
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CHAPTER 3 
Experimental Methods 
 
Animals and Tissues.  BXD1 through BXD42 mice are original RI strains available from 
the Jackson Laboratory (Bar Harbor, ME). BXD43 through BXD100 lines were generated 
using ninth or tenth generation Advanced Intercross Line (AIL) progenitors. AILs are 
generated by breeding two inbred parents (here is C57BL/6J and DBA/2J) and crossing 
their offspring so as to minimize inbreeding and maximize recombination events at each 
generation 28.  Mice were maintained at 20-24°C on a 14/10 hr light/dark cycle in a 
pathogen-free colony at the University of Tennessee-Memphis. Animals were fed a 5% 
fat Agway Prolab 3000 rat and mouse chow and given tap water in glass bottles.  Strain 
details are provided in Supplemental Table 1. Mice were raised to between 54 and 177 
days (mean 70 days) of age. Liver tissues were collected following sacrifice by cervical 
dislocation. The whole liver was removed immediately, and placed in five volumes of 
RNAlater (Ambion, Austin, TX) at 4°C overnight, before removing from RNAlater and 
storing at -80°C until processing. All animal studies for this project were approved by 
Animal Care and Use Committee at the University of Tennessee-Memphis. 
 
RNA Isolation. Total RNA was isolated from liver samples (~30 mg) using the RNeasy 
mini kit (Qiagen, Valencia, CA) as detailed by the manufacturer. RNA quality and quantity 
was determined spectrophotometrically from the absorbance at 260 nm and 280 nm. 
Aliquots of RNA samples were frozen at −80°C until microarray analysis. For each 
microarray, RNA was pooled from 2-3 mice of the same sex and strain. 
  
Microarray Analysis. One µg of total RNA from 3 individual mouse liver samples of the 
same sex and strain was pooled, amplified and labeled with a fluorescent dye (Cy5) and 
a common reference - pooled mouse tissues (equal amounts of RNA from liver, kidney, 
lung, brain and spleen) mRNA isolated from the livers of 100 male C57BL6/J mice [see 35 
for details] - were amplified and labeled with Cy3 using Agilent Technologies (Palo Alto, 
CA) Low RNA Input Linear Amplification labeling kit following the manufacturer’s protocol. 
The quantity of the resulting fluorescently labeled cRNA was measured using a Nanodrop 
ND-100 spectrophotometer (Nanodrop Technologies, Wilmington, DE) and its integrity 
assessed using an Agilent Bioanalyzer. Equal amounts of Cy3 and Cy5-labeled cRNA 
(750 ng) from the individual animals and from the pooled control, respectively, were 
hybridized to an Agilent Mouse Oligo Microarray (~21,000 features, catalogue# G4121) 
for 17 hours at 65°C. The hybridized microarrays were then washed and scanned using 
an Agilent G2565BA scanner. Data were extracted from the scanned image using Agilent 
Feature Extraction software version 6.1. A total of 122 arrays were run in 8 batches. The 
samples were semi-randomly distributed throughout the batches prior to microarray 
analysis in order to separate sexes and strains, and to minimize between- and within- 
batch bias. Technical and biological replicates were run both within each batch and 
between batches.  The microarray data was deposited in the UNC Microarray Database 
and extracted using Log2 ratios of the mean red channel intensity over the mean green 
channel intensity. This was followed by LOWESS normalization to remove the intensity 
dependent dye bias 36.  Neither the genes nor the arrays were centered.  Inter-batch 
normalization was carried out using a nested ANOVA mixed model with samples within 
each batch crossed with sex and strain. 
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 QTL Analysis and WebQTL.  QTL linkage mapping was carried out using the QTL 
Reaper software package (qtlreaper.sourceforge.net).  One thousand permutations of the 
strain labels were performed to estimate the genome wide p-value 37. Liver expression 
data was deposited in WebQTL (www.genenetwork.org) which is a web-based resource 
for exploring gene expression and phenotype interactions.  WebQTL was used to 
produce interval maps for specific genes. 
 
Transcriptome Map and Whole Genome QTL Clustering.  The transcriptome map of 
the liver was produced using the R statistical package using the output data from QTL 
Reaper which consisted of the maximum Likelihood Ratio Statistic (LRS) value for each 
transcript on the microarray as well as a permutation derived p-value (number of 
permutations = 1000). The p-value threshold was applied at a 25% False Discovery Rate 
38. The QTL data for all informative markers and 18,716 transcripts on the G4121A 
microarray was used to perform hierarchical clustering of the QTL data.  Transcripts were 
clustered using each 2,325 marker vector of LRS values. The distance metric used for 
complete (maximum distance) hierarchical clustering was "1 – Pearson  correlation" and 
colored by normalized LRS value. 
 
Transcription Factor Analysis. Three web-based tools were used to search for possible 
transcription factor binding sites in candidate loci: the National Cancer Institute’s 
Advanced Biomedical Computing Center promoter analysis tool 
(grid.abcc.ncifcrf.gov/promoters.php), oPossum version 1.3 39 and PAINT 40.  In the first 
two cases, transcripts were divided based on increased expression correlating with the 
C57BL/6J of DBA/2J allele. The transcripts were submitted in 4 groups: 1) high 
expression with the C57BL/6J allele and an LRS of 30 or greater, 2) high expression with 
the C57BL/6J allele and an LRS of 40 or greater, 3) high expression with the DBA/2J 
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 allele and an LRS of 30 or greater and 4) high expression with the DBA/2J allele and an 
LRS of 40 or greater.  With PAINT, all transcripts were submitted as one list, but a gene 
cluster file was also submitted that clustered the C57BL/6J high and DBA/2J high 
transcripts into separate clusters. 
 
Quantitative Real Time PCR analysis.  In order to test the hypothesis that Dicer1 might 
be the regulatory gene at the distal chromosome12 locus which controls the 111 
transcripts, female Dicer1 wild type and heterozygote mice 41 were obtained.  No 
knockout is available because Dicer1 is embryonic lethal. 10 genes that are trans-
regulated at this locus were selected (Abhd1, Dhrsx, Hnf4g, Met, Neurog3, Olfr656, Pms1, 
Runx3, Rqcd1, Sel1h).  9 genes were selected that are known to be expressed in the 
murine liver but do not have a significant or suggestive QTL on distal chromosome 12 
(Abcb11, Abcc2, Abcd3, Cyp2e1, Cyp3a11, Cyp7a1, Cyp8b1, Ppar1, Rara). RNA 
isolation was carried out using the Qiagen (Valencia, CA) RNeasy Mini Kit 50.  RNA 
concentration and quality was checked using the Nanodrop (Wilmington, DE) ND-1000 
spectrophotometer at the 260 and 280 nm wavelengths.  20 μg of RNA were used to 
produce cDNA using the Applied Biosystems Inc. (Foster City, CA) High Capacity cDNA 
Archive Kit. The Stratagene (La Jolla, CA) FullVelocity QYBR Green QPC Master Mix 
was used to perform the RTPCR and the plates were run on a Stratagene Mx3000P 
instrument.  
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CHAPTER 4 
Results and Discussion 
 
Genetic control of gene expression in liver 
 Using web-based eQTL mapping tools and data collected in this study, regulatory 
loci controlling each liver transcript can be easily visualized in WebQTL 
(www.genenetwork.org). Figure 1 shows examples of the three types of expression 
control found in the liver. A transcript with a maximum locus of control near (+/- 20 Mb) 
the genomic location of the transcript itself is considered to be cis-regulated 42. This 
implies some mechanism of control near the gene itself; perhaps a polymorphism in the 
promoter region. An example of a strong cis-regulated transcript is the cytochrome P450, 
family 3, subfamily a, polypeptide 13 (Cyp3a13) gene, located on distal chromosome 5 
(Figure 1a). A transcript with a maximum locus of control far from the gene location is 
trans-regulated. This implies regulation by another gene like a transcription factor. ADP-
ribosyltransferase 5 (Art5) gene, located in the middle of chromosome 7, is an example of 
a trans-regulated gene whose expression levels are determined by polymorphisms on 
chromosome 3 (Figure 1b). Interestingly, many liver-expressed transcripts are regulated 
by multiple loci.  The interleukin 21 receptor (Il21r) gene, located on distal chromosome 7, 
is a good example (Figure 1c). Il21r has two significant QTL peaks - one on chromosome 
7 proximal to the gene itself and one on chromosome 14.   
  
 
  
Figure 1.  WebQTL interval mapping reveals genetic control of gene expression. a, 
An example of a cis-regulated gene (Cyp3a13) where the QTL is co-located with the 
gene.  The horizontal axis displays the mouse genome.  The vertical axis displays the 
Likelihood Ratio Statistic (LRS), The gene location is shown by the red triangle. The red 
horizontal line indicates a significant level of association as determined by permutation 
analysis. The grey horizontal line below it represents a suggestive association. The blue 
line displays the LRS along the genome and the yellow bars are the results of a bootstrap 
analysis. The inset shows a zoomed-in view of the Cyp3a13 QTL on Chr5 (130-145Mb) 
and illustrates the features of WebQTL. The red line indicates that C57BL/6J alleles at 
the marker increase expression of the gene. The colored boxes along the top represent 
known genes which, when selected, will take the user to the NCBI EntrezGene entry for 
that gene. A SNP track is displayed along the bottom as an orange seismogram. b, An 
example a trans-regulated gene (Art5). c, An example of a gene (Il21r) that is regulated 
by multiple loci.  
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 To visualize the patterns of genetic control of gene expression on a genome-wide level, 
the 18716 annotated transcripts were clustered using the LRS vector for each transcript 
(Figure 2a).  As expected, the majority of the transcripts in liver are independently 
regulated; however, several distinct patterns emerge. Specifically, there are a number of 
clusters of transcripts that all share a common maximal QTL as well as clusters that are 
co-regulated by a complex set of common loci.  We refer to clusters regulated by only 
one strong QTL as “simple” QTL clusters and ones regulated by multiple loci as 
“complex” clusters. 
 Chromosome 8 contains a simple cluster of transcripts that all have a strong 
maximum QTL (mean LRS = 47.5, Figure 2b). Of the 27 transcripts in this cluster, 26 are 
located on chromosome 8 at the same location as the maximum QTL which indicates that 
this cluster contains predominantly cis-regulated genes or perhaps is due to a strain-
specific difference in a regional transcriptional enhancer. Interestingly, the presence of 
one of the parental (C57BL/6J or DBA/2J) allele at this locus strongly affects expression 
of these genes (Figure 2b, yellow-red correlation plot). 
 Chromosome 12 also contains a simple cluster that consists of a set of transcripts 
with a maximal QTL (mean maximum LRS = 42.6) at the distal region of the chromosome 
(Figure 2c).  However, only 5 of the 111 transcripts in this cluster are cis-regulated and  
 20
  
 
Figure 2. Genome-wide clustering of the genetic control of gene expression in liver. 
a, Hierarchical clustering diagram of all transcripts on the array by Likelihood Ratio 
Statistic (LRS) profile. Rows – transcripts on the microarray, columns – SNP markers 
used for the QTL analysis. Strength of the LRS values is depicted using a head map with 
black being the lowest LRS, and bright red – the highest. b, A zoomed-in view of the 
cluster of genes controlled by a single genetic locus on Chr8. An auto-correlation matrix 
of the measured expression values for the transcripts in the cluster and a plot of 
chromosomal location of these transcripts are shown below. c, A cluster of 111 
transcripts controlled by one locus on Chr12. d, A cluster of 43 transcripts that are 
controlled by a complex set of loci on several chromosomes. 
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 hence located under the maximal QTL. This region in the genome is a master-regulator 
since the majority of the transcripts are trans-regulated by this locus.  Again, the 
correlation between expression levels of these transcripts is strongly dependent on the 
type of the parental allele that is present at this locus implying a common regulator of all 
111 transcripts.   
 To further understand the genetic basis for the difference in the proportion of cis- 
and trans-regulated transcripts in simple clusters, 31 simple clusters comprised of at least 
80% cis-regulated transcripts were examined.  It was hypothesized that the clustering of 
these cis-regulated QTLs might be due to higher gene or SNP density as opposed to 
biological pathways. To determine why a large number of cis-regulated transcripts might 
be located in very small genetic loci gene density at each region was considered versus 
adjacent up- and down-stream regions.  For gene density, it was found that the QTL 
cluster regions had 79.5 ± 70.0 (mean ± SD) genes while the immediately adjacent up- 
and down-stream regions contained 45.0 ± 48.3 and 45.0 ± 44.2 genes, respectively.  For 
SNP density, it was found that the QTL cluster regions had 4362 ± 3707 SNPs and the 
up- and down-stream regions had 2924 ± 2963 and 3318 ± 3957 SNPs, respectively. In 
this analysis, only those SNPs that differ between the C57BL/6J and DBA/2J strains in 
the Perlegen mouse SNP data set (mouse.perlegen.com/mouse/index.html) were 
considered. Thus, on the level of individual clusters, QTL clustering may be driven by a 
combination of gene and SNP density. Furthermore, the transcripts in these cis-regulated 
clusters do not appear to be enriched for any particular GO category. This indicates that 
the co-regulation of cis-controlled genes throughout the genome is not due to functional 
relatedness, but rather the high gene/SNP density in each region. 
 Lastly, a cluster of 43 transcripts (Figure 2d) that are controlled by a complex 
pattern of loci across multiple chromosomes (mean maximum LRS = 13.3) is shown. Not 
surprisingly, these genes are scattered around the genome. The pair-wise gene 
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 expression correlation matrix for these transcripts shows that mRNA levels for these 
genes are highly positively correlated regardless of the allele type at each QTL.  
 The proportion of cis-eQTLs that had higher expression when the C57BL/6J allele 
is present was assessed. Following the criterion set out in Pierce et al. 43, a cis-eQTL was 
defined as a transcript that has a maximum QTL within +/- 5Mb of the transcript’s location 
in the genome.   At a genome wide p value of 0.05, 1,255 cis-eQTLs with 54.3% were 
found as having C57BL/6J high expression. At higher levels of statistical stringency 1,075 
cis-eQTLs (p = 0.01)  are found with 53.9% higher for the C57BL/6J allele and 867 cis-
eQTLs (p = 0.001) with 53.3% higher for the C57BL/6J allele. The data presented by 
Doss et al 42 and the data from this study both show only a slight (54-56%) enrichment for 
C57BL/6J high cis-eQTLs when Agilent long oligo arrays, produced from the reference 
sequence of the C57BL/6J strain, are used. Consequently, much higher (72-75%) 
enrichment in the Pierce et al. 43 data set could be attributed to a low fidelity binding of 
short oligos used on Affymetrix arrays. These results show that long oligo array platforms 
are more suitable for eQTL analysis. 
 
Mouse brain and liver transcriptomes show little overlap in genetic regulation of 
gene expression 
 Several recent reports identified a number of master-regulatory loci in other 
mouse tissues 6,7,43. Here, the mouse brain (forebrain) and liver transcriptome maps 
(Figure 3) are compared to uncover the similarities and differences in genetic regulation 
of gene expression across tissues. Both brain and liver contain genes that are strongly 
cis- or trans- regulated at single loci, or are regulated by multiple loci (Figures 3a and b, 
respectively). In the brain transcriptome, three distinct master-regulator trans-bands are 
located on chromosomes 1 and 2 (Figure 3c). In the liver transcriptome, the strongest 
trans-band is located on distal chromosome 12 (Figure 3d), a locus that does not appear 
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 to be controlling expression of a large number of genes in the brain. While the liver and 
the brain both have a trans-band on chromosome 2 near 125 Mb, the two bands are not 
coincident. The liver trans-band lies at 119 MB and the brain at 135 Mb - a difference of 
16 Mb.  
 Next, the QTL data for the liver and brain by selecting only those transcripts with a 
genome-wide p value ≤ 0.05 43 was filtered. This analysis identified 743 transcripts that 
have significant QTLs in both tissues (Figure 3e). It is interesting to note that 209 
transcripts are regulated by the same genomic region in both the liver and the brain 
(genes that fall of a diagonal in Figure 3e). Gene Ontology-based 44 analysis of the 
biological processes that are significantly over-represented (Fisher’s exact test p < 0.05 
and 25% FDR) among these genes identified a number of significant categories that are 
co-regulated in both tissues (Figure 3f). Furthermore, among the 743 transcripts, the 
proportion of cis-regulated transcripts in the liver was 0.59 and in the brain it was 0.55. 
The difference is due to slight differences in the transcript location between the two data 
sets. Of the 209 transcripts that have the same QTL in the liver and the brain about 95% 
are cis-regulated. Collectively, this comparison indicates that important tissue-specific 
patterns of genetic control of gene expression can be elucidated by this approach and 
potentially form the basis for comparative analyses between tissues. 
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Figure 3. Tissue-specific transcriptome maps reveal differences and similarities in 
genetic regulation of gene expression. a-b, The brain 43 and liver (this study) 
transcriptome maps.  The horizontal axis shows the genomic location of each genetic 
marker along the genome. The vertical axis shows the genomic location of each 
transcript probed by the microarray analysis.  Each cross represents the location of the 
maximum QTL for a particular gene. Cis-regulated genes, where the QTL is co-located 
with the gene, fall along a 45 degree line.  The vertical lines correspond to a locus with 
strong trans-control over many genes.  The major loci of control differ markedly in the 
murine brain and liver.  c-d, Histograms counting the proportion of transcripts on the 
array regulated at each marker.  e, A comparative transcriptome map between the murine 
liver and brain.  Significant QTLs in the liver and brain are plotted along the horizontal 
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 and vertical axes, respectively. Points along the diagonal represent transcripts whose 
maximum QTL is the same in both tissues, indicating a similar mechanism of expression 
control.  Points plotted off of the diagonal represent transcripts that are controlled by 
different loci in the two tissues. f, Gene Ontology analysis of the significantly enriched 
biological processes common between liver and brain in the mouse.  
 
Chromosome 12 contains a strong liver-specific master-regulatory locus  
 The chromosome 12 locus regulates expression of 111 genes and is delineated 
by two SNP markers, rs13481620 at 98.47783 Mb and rs8273308 at 99.83812 Mb 
(Figure 4, average LRS = 42.6, genome-wide p value < 0.03 and 0.25 False Discovery 
Rate 45). Surprisingly, the mean LRS for the transcripts that are cis-regulated (LRS = 
31.4) at this locus is lower than that for the trans-regulated (LRS = 43.1) ones.  It was 
hypothesized that this locus contains a gene that serves as a liver-specific “master 
regulator” of this chromosome 12 trans-band. To identify the candidate gene, genes in a 
4 Mb region (98 - 102 Mb) around the two eQTL markers identified above were 
considered (Figure 4, lower panel).  
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Figure 4. Chr12 locus is a master-regulator of gene expression in mouse liver.  A 
zoomed-in view of the region on Chr12 that controls a large number of trans-regulated 
transcripts is shown in the bottom panel. The middle panel is a detail of the QTL peak 
from 98 Mb to 102 Mb showing the genes in this region.  Genes labeled in blue text have 
non-synonymous coding SNPs.  Genes in italics are cis-regulated.  Genes in plain text 
are trans-regulated.  The gene location marker is color coded based on relative 
expression in the mouse liver.  Green indicates low expression; red indicates high 
expression; grey indicates that the gene is not represented on the microarray.  The top 
panel shows the correlation between the expression of each gene located in this locus 
and the putative trans-regulated genes.  Red indicates negative correlation; yellow 
indicates positive correlation; grey indicates no information.  Genes in the upper part of 
the panel are highly expressed in strains with the DBA/2J allele at this Chr12 locus.  
Genes on the bottom of the panel are highly expressed in strains with the C57BL/6J allele 
is at this locus.  
 
 
 It was reasoned that the candidate gene that may be responsible for the variation 
in expression between the transcripts associated with this locus should satisfy the 
following properties: 1) be cis-regulated at the chromosome 12 locus or contain non-
synonymous coding SNPs between parental alleles, 2) have median to high expression in 
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 liver and 3) exhibit strong correlation in gene expression between the candidate gene and 
the trans-regulated transcripts when separated by parental allele at this locus.  Five 
genes that are located in this region are cis-regulated: Dicer1, Serpina3k, Serpina3n, 
Serpina9 and Serpina12 (Figure 4, middle panel, genes identified in italics). Furthermore, 
a number of genes in this region, including Serpina3k, Serpina3n, Serpina9, and 
Serpina12, have known non-synonymous coding SNPs between the C57BL/6J and 
DBA/2J strains. Serpina3k, Serpina3n, Dicer1, Serpina9 and Serpina12, among several 
other genes, also have median to high relative mRNA expression in liver. Lastly, when 
the strength of the correlation between expression of each transcript regulated by this 
locus and expression of all other transcripts located in the chromosome 12 locus is 
plotted (Figure 4, top panel), it is evident that Dicer1, Serpina3k, Serpina3n, Serpina9, 
Serpina12 and four other transcripts have a clear separation (positive or negative 
correlation) according to the parental strain allele at this locus. Thus, it appears that any 
of the 5 cis-regulated genes at this locus: Dicer1, Serpina3k, Serpina3n, Serpina9, 
Serpina12 is likely to be the candidate "master regulator" gene in liver. 
 Dicer1 is a logical candidate for the chromosome 12 locus since it is involved in 
post-transcriptional regulation of genes via cleavage of double-stranded RNAs (dsRNA) 
into ~20-25 base pair fragments.  These fragments are then processed by the RNA-
induced silencing complex, which recognizes sequences complementary to the dsRNA 
and prevents protein synthesis through either mRNA degradation or inhibition of 
translation 46. To date, no specific gene regulatory function has been proposed for Dicer1 
in the liver. To test the hypothesis that Dicer1 is a master-regulator of gene expression in 
the liver, expression was compared between the chromosome 12 locus-regulated genes 
in livers of wild type and Dicer1 heterozygous [Dicer1 null mutation is embryonic lethal 41] 
mice by quantitative real time PCR. As a negative control, a number of randomly selected 
genes that are not regulated by the chromsome12 locus were selected. Contrary to our 
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 hypothesis, no consistent correlation was found between expression of Dicer1 and 
chromosome 12 locus-regulated genes (data not shown) which suggests that Dicer1 
does not appear to be the master regulator at this locus. It should be noted, however, that 
Dicer1 heterozygous mice may not be the most appropriate system for testing this 
hypothesis since Dicer1 mRNA levels in heterozygotes are 134% of wild type levels and 
a small sample size (n = 3 per group) limits the power of the analysis  (p = 0.17). 
 Next, other means of biological interpretation of the data were considered. Gene 
Ontology (GO) and transcription factor binding site analyses of the chromosome 12 locus 
trans-regulated genes were performed. GOMiner 47 examination of the 111 transcripts 
with maximum QTLs at the chromosome 12 locus identified significant enrichment for a 
single biological process category – cell surface receptor linked signal transduction 
(p=8.74x10-4). The genes from this category that are trans-regulated by the chromosome 
12 locus are mainly olfactory receptors: Bsf3, Rqcd1, Gpr50, Tcp10c, P2ry10, Olfr1403, 
Olfr1443, Olfr401, Olfr512, Olfr935, Olfr1341, Olfr341, Olfr656, Olfr1365, Mesp2, Met, 
Ltbp3, Fstl3, Centd2, and Rassf3. 
 For the transcription factor binding site analysis, the trans-regulated transcripts at 
the chromosome 12 locus (LRS values greater than or equal to 30) were divided into two 
groups: those with high expression when either C57BL/6J or DBA/2J allele is present at 
the chromosome 12 locus.  The National Cancer Institute’s Advanced Biomedical 
Computing Center promoter analysis tool (grid.abcc.ncifcrf.gov/promoters.php) found no 
common transcription factor binding sites for the C57BL/6J list.  LVc-Mo-MuLV and 
SV40.11 binding sites were identified as significant (p = 9.766e-04) in the DBA/2J list. 
The oPossum 39 tool identified Freac-2 site as significant in both C57BL/6J and DBA/2J 
lists (p = 6.026e-02 and p = 1.823e-02, respectively), while ARNT (p = 8.577e-02) and 
SOX-9 (p = 9.159e-02) sites were also found to be common for DBA/2J allele-containing 
genes. The PAINT transcription factor tool 40 was also applied to the data and no 
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 significant transcription factor binding sites between the two lists were found after FDR 
correction of the p-values. Similarly to our observation of the lack of a consistent signal 
for a transcription factor, Yvert et al. 48 and Kulp et al. 49 found that the genes in trans-
regulated bands are not enriched for transcription factors or biological function. This 
suggests that the trans-regulated genes at the chromosome 12 locus have a complex 
mechanism of regulation that is yet to be discovered. 
 The other candidates for the master regulator at the  chromosome 12 locus are 
Serpina3-family genes. These genes are the murine orthologs of human α1-anti-
chymotrypsin, a serine protease inhibitor. Serpina3n is an acute phase protein that 
increases 4 to 5-fold in inflammation and infection 50. In humans, α1-anti-chymotrypsin is 
an inhibitor of neutrophil elastase, cathepsin G, mast cell chymase & pancreatic 
chymotrypsin 51. In the mouse, Seprin3a targets are leukocyte elastase, cathepsin G and 
chymotrypsin 52.  While humans have one copy of α1-anti-chymotrypsin at 14q32, the 
mouse has 14 copies at 12E1 53. α1-Anti-chymotrypsin has been shown to be present in 
the amyloid plaques of Alzheimer’s patients 53. Elzouki et al. 54 found an association 
between low plasma α1-anti-chymotrypsin levels and propensity to contract the hepatitis 
B & C virus. A related protease inhibitor, serpina1 (α1-antitrypsin) is involved in 
emphysema due to a failure to inhibit neutrophil elastase and cirrhosis due to an 
accumulation of serpina1 polymers in the hepatocytes 51,55.  Although the overall structure 
is well conserved in the 14 member mouse Serpina3 family, the reactive center loop is 
widely divergent, suggesting that these enzymes have function other than protease 
inhibition. Interestingly, human α1-anti-chymotrypsin was reported to be able to bind to 
DNA and has been found to inhibit DNA polymerase and DNA primase in vitro 51.  
Horvath et al. 52 performed a detailed structural analysis of mouse SERPINA3N and 
found that it contains a DNA binding domain similar to one described in human α1-anti-
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 chymotrypsin 56. However, it was also reported that human α1-anti-chymotrypsin binds to 
double stranded DNA without specificity to known DNA binding motifs 56. It has also been 
shown that some serpins may require cofactors for activation 51 which raises the 
possibility that the behavior of the Serpina3 family changes depending on the 
environment. Collectively, while there is no firm evidence for the role of Serpina3 genes in 
regulation of gene expression, we posit that our data points to the potential novel role of 
this family of genes in regulating liver gene expression.  
 
eQTL analysis facilitates the discovery of novel genotype-phenotype correlations 
 WebQTL contains comprehensive manually curated publicly available data for 
phenotypic and gene expression profiling of a number of recombinant inbred and F2 
crosses in both mouse and rat along with the dense genetic marker maps for these 
strains. Thus, this data can be used to search for correlations between phenotypes, gene 
expression and genetic markers, i.e., to perform in silico genotype-phenotype association 
analysis. The inherent significance of the defined reference genetic populations, such as 
BXD RI strains, is in the ability to connect historical data generated in many laboratories 
to the exact genetic map of each strain. This provides an exceptional opportunity to add 
value and depth to the biological interpretation of the data from model organisms. Thus, 
even though the BXD RI panel of strains has not been used extensively to profile liver 
disease-specific responses, as compared to a wealth of behavioral phenotypes published 
over the years, it is not unreasonable to anticipate that more data will become available 
soon.  
 Here, to illustrate the power of combining genome-wide, liver expression profiling 
in a reference mouse panel with phenotype profiling, we identify several phenotypes that 
strongly correlate with the expression of liver transcription factor hepatocyte nuclear 
factor 4-gamma (Hnf4g, located on Chr3 at 3.620141 Mb) using standard tools available 
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 in WebQTL. Hnf4g is trans-regulated by the chromosome 12 locus (Figure 5, left panel). 
Several of the BXD phenotypes are also regulated by this locus and there is strong 
correlation (Figure 5, right panel) between Hnf4g expression and the induction of serum 
IL-6 after TNF injection, lethality due to TNF injection and decreased body temperature 
after TNF injection 57. Furthermore, both the expression of Hnf4g and values of these 
phenotypes separate by parental allele at the location of the Hnf4g gene on proximal 
chromosome 3.  
 
Figure 5. In silico discovery of gene expression to phenotype correlations using 
WebQTL.  The left panel shows QTL interval maps on Chr12 for hepatocyte nuclear 
factor 4, gamma (Hnf4g) gene and three related phenotypes. The right panel shows 
correlation pair-wise correlation plots for Hnf4g expression and the phenotypes. Each dot 
represents the measurements for one strain.  Blue dots indicate strains in which the 
C57BL/6J allele is present at the Chr12 (99.83Mb) locus.  Red crosses represent strains 
with the DBA/2J allele at this locus. The blue histograms along the diagonal represent the 
distribution of all values of the phenotype.  
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 Knowledge of the variability in basal gene expression in liver as a tool for selecting 
relevant strains to probe biology 
 Genetic engineering has been a powerful and useful tool in biomedical research. 
However, there are a number of instances when generating a knockout or knockin mouse 
is neither the best option, nor it is feasible. The process is both costly and lengthy. 
Furthermore, some genes are embryonic lethal while others are sufficiently redundant, 
thus limiting the ability to generate biologically meaningful data using genetic engineering 
approaches. Thus, we propose that understanding of the degree of variability in gene 
expression between strains in a reference population of mice may be used to model the 
potential biological effects of naturally occurring differences in mRNA levels between 
individuals. In fact, it is extremely rare that people are complete nulls for a particular gene, 
but the polymorphisms in certain genes are known to predispose the individuals to some 
exposures or lead to disease 58,59.  Accordingly, the liver expression data in WebQTL may 
be utilized to select strains that differ in basal mRNA level of genes of interest and then 
used for phenotypic studies that are designed to test the role of the genes in a particular 
phenotype.  
 The flavin-containing mono-oxygenases are a class of phase I enzymes that 
oxidize organic nitrogen and sulfur containing compounds such as cimitidine, 
methimazole and nicotine 60-62.  Fmo3 is the most common isoform in the human liver 63.  
While no sex differences in human activity of Fmo3 have been shown, in mice Fmo3 
expression has been shown to be much higher in females 63,64.  Basal expression of 
Fmo3 varies widely across the BXD strains (Figure 6, top panel). We confirmed this by 
running quantitative real time PCR on strains with high, medium and low expression of 
Fmo3 in 9 out of 40 strains (Figure 6, lower panel). The correlation between the 
expression measured by microarray and PCR is strong (R2 = 0.74). Thus, WebQTL can 
be used to query the expression database to find genes with the highest differential 
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 expression across strains to generate a potential list of candidate strains for hypothesis 
testing. Since Fmo3 expression varies widely across BXD strains and mutations in this 
gene have been implicated in trimethylaminuria 58, a disease in which trimethylamine is 
not metabolized but is excreted in the breath and sweat, leading to a persistent fishy body 
odor, we suggest that BXD strains with high or low relative expression of Fmo3 may be 
used to model this disease. Similar logic may be used to test other genes without the cost 
and time of generating knockout animals. 
 
Figure 6.  WebQTL-assisted strain selection for phenotypic profiling. The main 
panel shows relative expression of Fmo3 (flavin monooxygenase 3) across BXD strains 
measured by microarray. Red circles are values in females; blue squares – in males and 
the strain means are shown as black circles. The lower panels show relative Fmo3 
expression in select strains as measured by microarray vs. quantitative real time PCR. 
The expression of Fmo3 in BXD21 strain was set to 0. 
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CHAPTER 5 
Conclusions and Future Directions 
 
 In conclusion, this study describes a new public resource that will facilitate our 
understanding of the genetic regulation of gene expression in liver. We describe several 
genetic loci that control expression of large numbers of genes. By using eQTL mapping, 
we identified the Serpina3 family of genes as potential novel master regulators of 
transcription in the liver. By comparing the liver and brain transcriptome maps, we 
highlighted tissue-specific differences in regulation of gene expression. Finally, this study 
demonstrates how this publicly available data may be used to infer genotype-phenotype 
correlations, generate testable hypothesis, and select mouse strains for further testing 
based on the genetically-determined differences of expression of the key genes.   
 
What gene(s) regulates the Chr 12 trans-QTL band? 
 
 The work presented above regarding the chromosome 12 trans-regulated band 
could be further extended by examining the corresponding set of genes in a separate 
panel of inbred mice.   Data has recently been generated in the Rusyn laboratory in which 
the constitutive gene expression of a panel of 36 strains of inbred strains was measured.   
Each strain consists of 2 or 3 microarrays from each strain.   Although all samples in this 
inbred data set are male, the chromosome 12 eQTLs have lower p-values in the BXD 
male samples and this single sex analysis will not present a problem.  These 36 inbred 
strains are part of the Novartis genotyping project.   This project has genotyped 71 inbred 
 strains (including the 36 strains above) at over 150,000 markers.  The increased density 
as well as the large number of strains should provide both confirmation of the genes truly 
regulated by the chromosome 12 locus and a narrower QTL to permit inference of the 
regulatory gene(s). 
 Once we have selected a small set of putative regulatory genes, cultures of 
primary hepatocytes from a subset of the BXD strains will be prepared.  First, the stability 
of the eQTL trans-band in vitro will be determined.  The expression of genes with high 
expression when the C57BL/6J allele is present at the chromosome 12 locus should 
remain higher than the expression of genes that are low when the DBA/2J locus is 
present.  RTPCR will be used to measure a subset of the trans-regulated genes that 
appear in both the BXD and inbred data sets.  Once this is established, the levels of 
mRNA of the putative regulatory genes will be knocked down using RNAi technology65,66.   
RTPCR will then be used to measure the expression of the expected regulator and a 
subset of positively and negatively correlated genes that are regulated by this locus.  The 
hypothesis is that when the regulatory gene(s) is knocked down, the expression levels of 
the corresponding regulated genes will increase or decrease depending on the direction 
of their correlation with the regulatory gene.   
 
What role do microRNAs play in the regulation of gene expression? 
 
The use of microarrays to measure gene expression leads naturally to a focus on 
polymorphism in genes and their promoter regions as the causative explanation for the 
variation in gene expression.  However, recent evidence shows that RNA interference 
influences the levels of mRNA transcripts in the cell46.   Briefly, double stranded RNA 
(dsRNA) is transcribed in the nucleus, exported to the cytoplasm and cleaved into 21 to 
23 nucleotide long small interfering RNAs (siRNA) by Dicer.  One strand of the dsRNA 
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 associates with the RNA-induced silencing complex (RISC) which recognizes the 
complementary RNA sequences and targets mRNA for destruction46.  There are other 
proposed mechanisms by which RNA interference (RNAi) affects expression levels.   The 
siRNA may bind to the mRNA and inhibit translation without actually destruction of the 
mRNA.  siRNA may also prevent transcription by binding to DNA  at promoter sites or 
affecting methylation status46.   
Microarrays have been developed67,68 that measure the levels of microRNA 
expression.  There are about 385 known mouse microRNAs currently in the Sanger 
microRNA data base69,70.  Working with collaborators at Oak Ridge National Labs, the 
expression of known microRNAs will be measured in the livers of the BXD mouse panel 
and these will be correlated with gene expression and used to find the causative 
polymorphisms underlying individual QTLs71.  There is one important caveat.  If siRNA 
prevents transcription or acts through transcriptional degradation and there is a 
polymorphism that affects siRNA binding, then it should be possible to measure 
differences in target transcript abundances.  However, if the siRNA operates through 
translational repression, then transcript levels measured in the BXD panel will not be 
altered and no QTL will be evident71. 
 
What is the role of sex on constitutive gene expression? 
 
 The effect of sex on the control of gene expression was not evaluated in this study.   
Although there is only one microarray per sex per strain, this type of analysis could 
provide preliminary insight and testable hypotheses.   The location of the trans-regulated 
bands differs by sex.  A transcriptome map of the male data (not shown) reveals trans-
bands on proximal chromosome 7 and distal chromosome 12.  The same plot with the 
female data chromosomes 1, 4, 6, 11, 12, 15 & 19.   Clusters of co-regulated genes that 
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 differ in expression by sex were compiled by ORNL using a new clique finding algorithm72.   
These clusters will be examined for biological relevance using the Gene Ontology, Kyoto 
Encyclopedia of Genes and Genomes, and Ingenuity Pathway Analysis.   
 In summary, genetical genomics is a powerful approach to understanding the 
genetic basis of gene expression.  When gene expression is a heritable trait, panels of 
recombinant inbred mice can be used to dissect the networks of co-regulated genes that 
vary due to genetic polymorphisms across strains.  These networks and the loci that 
regulate their expression offer insight into the working of the liver and provide data that 
can be correlated with phenotypic measurements for mechanistic hypothesis generation. 
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 Table 1 : Microarray Experiment Batch Design 
  COMPLEMENT 1 
    Batch 1 Batch 2 Batch 3 Batch 4 
Strain M F M F M F M F 
C57BL/6J   614 5 8 5 506 5   5 
    614   8   506     5 
              605   823 
DBA/2J     1 4 1 509 1   1 
          3       607 
B6D2F1   609   603 601 702 602    
                    
BXD1   9               
BXD12     13             
BXD11       12           
BXD13         16         
BXD14           17       
BXD15             19     
BXD16               803   
BXD23   24             704 
BXD34     43             
BXD21       21           
BXD24                 25 
BXD33                   
BXD9             70     
BXD19                 804 
BXD28   29               
BXD29     30             
BXD31       34           
BXD32         36     701   
BXD36           46       
BXD38             52     
BXD39   54               
BXD40     59         60   
BXD42       63           
BXD5         65         
BXD6           69       
BXDA23 BXD86               819 
BXD2                   
BXD8     613         817   
BXD69                 813 
BXD73               816   
BXD92                 821 
BXDA10 BXD77 500+501               
BXDAP11 BXD51             77   
BXDAP15 BXD62     79         812 
BXDAP19 BXD43       81         
BXDAP5 BXD60         86       
BXDAP6 BXD44           87     
BXDAP8 BXD48                 
BXDA22 BXD85               818 
BXDAP12 BXD45                 
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     Batch 5 Batch 6 Batch 7 Batch 8 
Strain M F M F M F M F 
C57BL/6J     5 507 5   5   5 
      5   5   5   5 
                    
DBA/2J     1 510 1 511 1   1 
                    
B6D2F1                 801 
                    
BXD1     11             
BXD12   14               
BXD11                 703 
BXD13   15               
BXD14                 610 
BXD15   18               
BXD16                 802 
BXD23                   
BXD34       42           
BXD21         20         
BXD24       26           
BXD33         40       809 
BXD9       71           
BXD19               805   
BXD28     28             
BXD29           31       
BXD31         32         
BXD32                   
BXD36                 48 
BXD38           51       
BXD39                 56 
BXD40                   
BXD42             62     
BXD5           66       
BXD6             68     
BXDA23 BXD86             901   
BXD2         612     611   
BXD8                   
BXD69               814   
BXD73                 815 
BXD92               822   
BXDA10 BXD77   499             
BXDAP11 BXD51               902 
BXDAP15 BXD62                 
BXDAP19 BXD43         82       
BXDAP5 BXD60   84             
BXDAP6 BXD44     502+503           
BXDAP8 BXD48     512         92 
BXDA22 BXD85             903   
BXDAP12 BXD45   515         811   
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 Table 2 : BXD strain information 
Strain Name Sex 
C57BL/6J M and F 
DBA/2J M and F 
B6D2F1 M and F 
BXD1 M and F 
BXD2 M and F 
BXD5 M and F 
BXD6 M and F 
BXD8 M and F 
BXD9 M and F 
BXD11 M and F 
BXD12 M and F 
BXD13 M and F 
BXD14 M and F 
BXD15 M and F 
BXD21 M and F 
BXD23 F 
BXD24 M 
BXD28 M and F 
BXD29 M and F 
BXD31 M and F 
BXD32 M and F 
BXD33 F 
BXD34 M and F 
BXD38 M and F 
BXD39 M and F 
BXD40 M and F 
BXD42 M and F 
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 BXD43 M and F 
BXD44 M and F 
BXD45 M and F 
BXD48 M and F 
BXD51 M and F 
BXD60 M and F 
BXD62 M and F 
BXD69 M and F 
BXD73 M and F 
BXD77 M and F 
BXD85 M and F 
BXD86 M and F 
BXD92 M and F 
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